Compare Stocks: ACH, VMD, TACO, and BDSX

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ACH Accendra Health	$1.23 +1.2%	$2.68	$0.93 ▼ $5.69	$93.06M	1.58	2.21 million shs	678,497 shs
BDSX Biodesix	$26.83 -5.8%	$22.63	$5.26 ▼ $31.31	$283.08M	0.56	135,541 shs	108,445 shs
TACO Berto Acquisition	$10.48 +0.1%	$10.47	$10.11 ▼ $10.65	$341.91M	0.07	36,208 shs	20,626 shs
VMD Viemed Healthcare	$8.82 -2.1%	$10.83	$6.05 ▼ $12.61	$335.94M	1.1	527,383 shs	294,110 shs

7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ACH Accendra Health	0.00%	+2.08%	-63.32%	-56.87%	+122,499,900.00%
BDSX Biodesix	0.00%	+0.75%	+25.79%	+64.40%	+185.43%
TACO Berto Acquisition	0.00%	+0.19%	+0.38%	0.00%	+1.65%
VMD Viemed Healthcare	0.00%	-0.34%	-25.00%	-10.37%	+22.84%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ACH Accendra Health	$1.23 +1.2%	$2.68	$0.93 ▼ $5.69	$93.06M	1.58	2.21 million shs	678,497 shs
BDSX Biodesix	$26.83 -5.8%	$22.63	$5.26 ▼ $31.31	$283.08M	0.56	135,541 shs	108,445 shs
TACO Berto Acquisition	$10.48 +0.1%	$10.47	$10.11 ▼ $10.65	$341.91M	0.07	36,208 shs	20,626 shs
VMD Viemed Healthcare	$8.82 -2.1%	$10.83	$6.05 ▼ $12.61	$335.94M	1.1	527,383 shs	294,110 shs

7 Best Space Stocks to Own in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ACH Accendra Health	0.00%	+2.08%	-63.32%	-56.87%	+122,499,900.00%
BDSX Biodesix	0.00%	+0.75%	+25.79%	+64.40%	+185.43%
TACO Berto Acquisition	0.00%	+0.19%	+0.38%	0.00%	+1.65%
VMD Viemed Healthcare	0.00%	-0.34%	-25.00%	-10.37%	+22.84%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ACH Accendra Health	1.80	Reduce	$1.50	22.45% Upside
BDSX Biodesix	2.80	Moderate Buy	$31.33	16.78% Upside
TACO Berto Acquisition	1.00	Sell	N/A	N/A
VMD Viemed Healthcare	2.25	Hold	$14.00	58.73% Upside

Current Analyst Ratings Breakdown

Latest ACH, VMD, TACO, and BDSX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/24/2026	TACO Berto Acquisition	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D-) ➝ Sell (D)
8/24/2026	VMD Viemed Healthcare	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Outperform	$14.00
8/21/2026	BDSX Biodesix	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/17/2026	VMD Viemed Healthcare	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy (B-) ➝ Hold (C+)
8/13/2026	ACH Accendra Health	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Neutral	$4.50 ➝ $1.50
8/11/2026	ACH Accendra Health	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target	Outperform ➝ Neutral	$1.50
8/11/2026	ACH Accendra Health	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Outperform ➝ Neutral	$1.50
8/10/2026	ACH Accendra Health	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$4.50 ➝ $1.50
8/10/2026	BDSX Biodesix	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$27.00 ➝ $35.00
8/6/2026	ACH Accendra Health	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/6/2026	BDSX Biodesix	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$26.00 ➝ $27.00

(Data available from 8/30/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ACH Accendra Health	$2.73B	0.03	$3.83 per share	0.32	($7.16) per share	-0.17
BDSX Biodesix	$88.50M	3.20	N/A	N/A	$0.87 per share	30.84
TACO Berto Acquisition	N/A	N/A	N/A	N/A	N/A	N/A
VMD Viemed Healthcare	$270.28M	1.24	$1.15 per share	7.66	$3.83 per share	2.30

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ACH Accendra Health	-$1.10B	-$3.91	N/A	13.61	N/A	-11.41%	-4.02%	0.70%	N/A
BDSX Biodesix	-$35.26M	-$3.17	N/A	N/A	N/A	-26.97%	-788.19%	-30.33%	11/2/2026 (Estimated)
TACO Berto Acquisition	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
VMD Viemed Healthcare	$14.93M	$0.36	24.50	18.38	2.18	4.81%	10.16%	7.22%	11/4/2026 (Estimated)

Latest ACH, VMD, TACO, and BDSX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2026	Q2 2026	TACO Berto Acquisition	N/A	$0.03	N/A	$0.03	N/A	N/A
8/10/2026	Q2 2026	ACH Accendra Health	-$0.13	-$0.19	-$0.06	-$1.16	N/A	$613.23 million
8/5/2026	Q2 2026	BDSX Biodesix	-$0.9018	-$0.71	+$0.1918	-$0.71	$26.03 million	$26.86 million
8/3/2026	Q2 2026	VMD Viemed Healthcare	$0.12	$0.07	-$0.05	$0.07	$78.00 million	$78.10 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ACH Accendra Health	N/A	N/A	N/A	N/A	N/A
BDSX Biodesix	N/A	N/A	N/A	N/A	N/A
TACO Berto Acquisition	N/A	N/A	N/A	N/A	N/A
VMD Viemed Healthcare	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ACH Accendra Health	N/A	0.41	0.30
BDSX Biodesix	5.12	2.85	2.85
TACO Berto Acquisition	N/A	N/A	N/A
VMD Viemed Healthcare	0.04	1.13	1.02

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ACH Accendra Health	N/A
BDSX Biodesix	20.96%
TACO Berto Acquisition	N/A
VMD Viemed Healthcare	74.24%

Insider Ownership

Company	Insider Ownership
ACH Accendra Health	2.29%
BDSX Biodesix	23.20%
TACO Berto Acquisition	13.20%
VMD Viemed Healthcare	20.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ACH Accendra Health	6,500	76.90 million	75.14 million	N/A
BDSX Biodesix	220	10.55 million	8.10 million	No Data
TACO Berto Acquisition	7,892	32.62 million	28.32 million	No Data
VMD Viemed Healthcare	1,382	38.09 million	30.24 million	Not Optionable

ACH, VMD, TACO, and BDSX Headlines

Recent News About These Companies

Viemed Healthcare Targets Low-20% Growth as Home Ventilation Opportunity Expands

August 29 at 10:01 AM | marketbeat.com

Nantahala Capital Management LLC Makes New Investment in Viemed Healthcare, Inc. $VMD

August 29 at 6:39 AM | marketbeat.com

Raffles Associates LP Acquires Shares of 403,691 Viemed Healthcare, Inc. $VMD

August 28 at 5:52 AM | marketbeat.com

533,466 Shares in Viemed Healthcare, Inc. $VMD Bought by Punch & Associates Investment Management Inc.

August 27 at 6:16 AM | marketbeat.com

403,691 Shares in Viemed Healthcare, Inc. $VMD Purchased by Raffles Associates LP

August 26, 2026 | marketbeat.com

Expect Equity LLC Purchases New Holdings in Viemed Healthcare, Inc. $VMD

August 26, 2026 | marketbeat.com

Barrington Research Initiates Coverage on Viemed Healthcare (NASDAQ:VMD)

August 26, 2026 | americanbankingnews.com

Viemed Healthcare (NASDAQ:VMD) Now Covered by Barrington Research

August 24, 2026 | marketbeat.com

Martin & Co. Inc. TN Purchases Shares of 340,771 Viemed Healthcare, Inc. $VMD

August 23, 2026 | marketbeat.com

Bard Associates Inc. Makes New $3.87 Million Investment in Viemed Healthcare, Inc. $VMD

August 22, 2026 | marketbeat.com

Tocqueville Asset Management L.P. Purchases New Shares in Viemed Healthcare, Inc. $VMD

August 21, 2026 | marketbeat.com

209,066 Shares in Viemed Healthcare, Inc. $VMD Acquired by Rice Hall James & Associates LLC

August 19, 2026 | marketbeat.com

GSA Capital Partners LLP Invests $1.46 Million in Viemed Healthcare, Inc. $VMD

August 17, 2026 | marketbeat.com

Viemed Healthcare (NASDAQ:VMD) Lowered to "Buy" Rating by Wall Street Zen

August 15, 2026 | marketbeat.com

Viemed Healthcare (NASDAQ:VMD) Stock Rating Lowered by Freedom Capital

August 7, 2026 | marketbeat.com

Viemed Healthcare, Inc. (VMD) Q2 2026 Earnings Call Transcript

August 4, 2026 | seekingalpha.com

Viemed Healthcare Q2 Earnings Call Highlights

August 4, 2026 | marketbeat.com

Viemed Healthcare, Inc. (VMD) Lags Q2 Earnings Estimates

August 3, 2026 | zacks.com

Viemed Healthcare (NASDAQ:VMD) Releases Quarterly Earnings Results, Misses Estimates By $0.05 EPS

August 3, 2026 | marketbeat.com

Viemed Healthcare Announces Second Quarter 2026 Financial Results

August 3, 2026 | accessnewswire.comA

Lazard Asset Management LLC Increases Position in Viemed Healthcare, Inc. $VMD

August 3, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

ACH, VMD, TACO, and BDSX Company Descriptions

Accendra Health NYSE:ACH

$1.23 +0.02 (+1.24%)

As of 08/28/2026 03:58 PM Eastern

Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.

Biodesix NASDAQ:BDSX

$26.83 -1.65 (-5.79%)

As of 08/28/2026 04:00 PM Eastern

Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR and NGS, and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.

Berto Acquisition NASDAQ:TACO

$10.48 +0.01 (+0.10%)

As of 08/28/2026 03:59 PM Eastern

Del Taco Restaurants, Inc. develops, franchises, owns, and operates Del Taco quick-service Mexican-American restaurants in the United States. The company's restaurants offer Mexican inspired and American classic dishes. As of August 31, 2021, it operated approximately 600 restaurants across 16 states. The company was founded in 1964 and is headquartered in Lake Forest, California.

Viemed Healthcare NASDAQ:VMD

$8.82 -0.19 (-2.11%)

As of 08/28/2026 04:00 PM Eastern

Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ACH, VMD, TACO, and BDSX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ACH, VMD, TACO, and BDSX Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ACH, VMD, TACO, and BDSX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

ACH, VMD, TACO, and BDSX Company Descriptions

Accendra Health NYSE:ACH

Biodesix NASDAQ:BDSX

Berto Acquisition NASDAQ:TACO

Viemed Healthcare NASDAQ:VMD

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ACH, VMD, TACO, and BDSX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ACH, VMD, TACO, and BDSX Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ACH, VMD, TACO, and BDSX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

ACH, VMD, TACO, and BDSX Company Descriptions

Accendra Health NYSE:ACH

Biodesix NASDAQ:BDSX

Berto Acquisition NASDAQ:TACO

Viemed Healthcare NASDAQ:VMD

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools